Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source

Medical Physics

Volumn 28, Issue 4, 2001, Pages 661-670

  Duggan, D M ^a   Johnson, B L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

125I; Brachytherapy; Dosimetry; Task Group 43

Indexed keywords

ANISOTROPY; DOSIMETRY; IODINE; LITHIUM COMPOUNDS; ONCOLOGY; PHANTOMS; RADIOTHERAPY; RATE CONSTANTS;

BRACHYTHERAPY; DOSE RATE CONSTANTS; PLASTIC PHANTOM; RADIAL DOSE FUNCTION; TASK GROUPS; THERMOLUMINESCENT DOSIMETERS; WATER EQUIVALENT; ^125I;

SEED;

IODINE 125;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; DOSIMETRY; PHANTOM; PRIORITY JOURNAL; THERMOLUMINESCENCE;

EID: 0035045005     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1357456     Document Type: Article

References (43)

1. The use of iodine-125 plaques in the treatment of retinoblastoma
2. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques
3. Implant brachytherapy: A novel treatment for recurrent orbital rhabdomyosarcoma
4. Review of eye plaque dosimetry based on AAPM Task Group 43 recommendations. American Association of Physicists in Medicine
5. Palladium-103 plaque radiotherapy for choroidal melanoma: Results of a 7-year study
6. Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources
7. Stereotactic interstitial irradiation of diencephalic tumors with iridium 192 and iodine 125: 10 Years follow-up and comparison with other treatments
8. A 10-year experience of pediatric brachytherapy
9. Interstitial brachytherapy for malignant brain tumors
10. Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-Year tumor control and morbidity
11. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer
12. The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.
13. Brachytherapy in early prostate cancer - Early experience
14. Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in medicine Task Group No. 64
15. Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer
16. Complications after prostate brachytherapy in the Medicare population
17. Calculated dosimetric parameters of the IoGold 125I source model 3631-A
18. Evaluation of a new brachytherapy iodine-125 source by AAPM TG43 formalism
19. Report on the dosimetry of a new design 125Iodine brachytherapy source
20. Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source
21. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed
22. 125I brachytherapy source
23. Two-dimensional dose distribution of 125I seeds
24. Two-dimensional dose distribution around a commercial 125I seed
25. Dose parameters of 125I and 192Ir seed sources
26. Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sources
27. A comparison of radial dose functions for 103Pd, 125I 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources
28. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources
29. Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study
30. Anisotropy functions for 125I and 103Pd sources
31. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine
32. Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources. Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee. Ad Hoc Subcommittee of the Radiation Therapy Committee
33. Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds
34. Characteristics of 125I source for interstitial brachytherapy
35. A protocol for the determination of absorbed dose from high-energy photon and electron beams
36. CT-based dosimetry calculations for 125I prostate implants
37. 125I photons
38. Guidance to users of Nycomed Amersham and North American Scientific, Inc., I-125 interstitial sources: Dosimetry and calibration changes: Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry
39. Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 kev to 2 MeV: EGS4 Monte Carlo model calculation
40. Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43. American Association of Physicists in Medicine
41. 125I seeds of a new design for interstitial implant